MID PRICE
100.01
par = 100
YIELD TO MAT.
5.28%
semi-annual
COUPON
5.200%
semi-annual · fixed
MATURITY
2035-09-25
bullet · 9.38y
OUTSTANDING
—
not disclosed
AS OF
2026-05-07
Sign up free to see prices on this bond
Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.
About this bond
AI BRIEF · GROUNDED IN STRUCTURED DATAAbout the issuer
Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.
Source: Wikipedia →Risk analytics
SEMI-ANNUAL · BULLET · PAR 100Modified duration
7.30 y
1bp ↑ ≈ -0.073% P&L
Convexity
64.89
higher = more curvature
Years to maturity
9.38 y
YTM source
Ingested
Market signals · funds disclosing this bond
Subscribe to reveal which signals are holding this bond.Subscribe →
Price history
Sherpa Signal
AS OF 2026-05-07Institutional footprint · signal-level holdings
Interpretation. Moderate institutional footprint, with net accumulation
HOLDERS
19
▲ 5 signals in 7d
AGGREGATE EXPOSURE
$55.2M
USD across all
TOP CONCENTRATION
41.1%
largest holder
FLOW
▲ $9.7M
▲ 5 signals in 7d
Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.
100K PAR NOTIONAL · MARKET VALUE
100,007 USD
PRICE
100.01
RFQ routing · coming soon
Security details
VIA OPENFIGICanonical
RPRX 5.2 09/25/35
FIGI
BBG01X0X8FQ3
CUSIP
78081BAU7
ISIN
US78081BAU70
Type
Corp
Issued
2025-09-16
Face value
100 USD
Ticker
RPRX 5.2 09/25/35
Sec. type
GLOBAL
Seniority
Senior Unsecured
Issuer curve
RPRX · 10 PTSYield (%) plotted against years-to-maturity. This bond highlighted in amber.
Bonds like this
HEURISTICSame currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.
2034-09
5.20%
−8 bps yield−1y duration8 signals in commonSame issuer
2031-09
4.79%
−49 bps yield−4y duration8 signals in commonSame issuer
2031-03
4.73%
−55 bps yield−5y duration6 signals in commonSame issuer
2030-09
4.68%
−60 bps yield−5y duration9 signals in commonSame issuer
2029-09
4.60%
−68 bps yield−6y duration6 signals in commonSame issuer
2027-09
4.44%
−84 bps yield−8y duration6 signals in commonSame issuer